Katherine E Ward's research while affiliated with University of Notre Dame and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (17)
Group IV phospholipase A2α (cPLA2α) regulates the production of prostaglandins and leukotrienes via the formation of arachidonic acid from membrane phospholipids. The targeting and membrane binding of cPLA2α to the Golgi involves the N-terminal C2 domain, whereas the catalytic domain produces arachidonic acid. Although most studies of cPLA2α concer...
Group IV phospholipase A2α (cPLA2α) regulates the production of prostaglandins and leukotrienes via the formation of arachidonic acid from membrane phospholipids. The targeting and membrane binding of cPLA2α to the Golgi involves the N-terminal C2 domain whereas the catalytic domain produces arachidonic acid. Although most studies of cPLA2α concern...
Ceramide-1-phosphate (C1P) is an important signaling sphingolipid and a metabolite of ceramide. C1P contains an anionic phosphomonoester head group and has been shown to regulate physiological and pathophysiological processes such as cell proliferation, inflammation, apoptosis, phagocytosis, and macrophage chemotaxis. Despite this mechanistic infor...
The bioactive sphingolipid, ceramide 1-phosphate (C-1-P), has been implicated as an extracellular chemotactic agent directing cellular migration in hematopoietic stem/progenitor cells and macrophages. However, interacting proteins that could mediate these actions of C-1-P have, thus far, eluded identification. We have now identified and characteriz...
Signal transduction mediates disease through key molecular targets in the cell. As protein‐lipid interactions have been examined in the literature, their role in cellular signaling has become more prevalent. Lipid‐binding proteins have become high impact drug targets in cancer, inflammation and viral egress. One such target, termed cytosolic phosph...
Mechanisms that alter protein phosphatase 2A (PP2A)-dependent lung tumour suppression via the I2PP2A/SET oncoprotein are unknown. We show here that the tumour suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as determined by molecular modelling/simulations and site-directed mutagenesis. Becaus...
Group IVA cytosolic phospholipase A(2) (cPLA(2)α), which harbors a N-terminal lipid binding C2 domain and a C-terminal lipase domain produces arachidonic acid from the sn-2 position of zwitterionic lipids such as phosphatidylcholine. The C2 domain has been shown to bind zwitterionic lipids but more recently the anionic phosphomonoester sphingolipid...
Group IVA cytosolic phospholipase A(2) (cPLA(2)α) is an 85-kDa enzyme that regulates release of arachidonic acid (AA) from the sn-2 position of membrane phospholipids. It is well established that cPLA2α binds zwitterionic lipids such as phosphatidylcholine in a Ca(2+)-dependent manner through its N-terminal C2 domain, which regulates its translocat...
Protein kinase Cθ (PKCθ) is a novel PKC that plays a key role in T lymphocyte activation. To understand how PKCθ is regulated
in T cells, we investigated the properties of its N-terminal C2 domain that functions as an autoinhibitory domain. Our measurements
show that a Tyr(P)-containing peptide derived from CDCP1 binds the C2 domain of PKCθ with hi...
The activation of cytosolic phospholipase A2 α (cPLA2α) has been implicated in atherosclerosis and cerebral ischemia in previous animal models. The sphingolipid metabolite ceramide‐1‐phosphate (C1P) is known to specifically regulate the activation of cPLA2α and has been shown to increase enzymatic activity 5–10 fold through increased membrane resid...
Tumor necrosis factor α (TNFα) is a well known cytokine involved in systemic and acute inflammation. In this study, we demonstrate
that ceramide 1-phosphate (C1P) produced by ceramide kinase (CERK) is a negative regulator of LPS-induced TNFα secretion.
Specifically, bone marrow-derived macrophages isolated from CERK knock-out mice (CERK−/−) generat...
This manuscript was withdrawn by the author.
Cytosolic phospholipase A2‐alpha (cPLA 2 α) has been a protein of interest for over 16 years because of its presence in inflammatory diseases, including asthma and rheumatoid arthritis. cPLA 2 α is composed of two domains, a catalytic domain that generates arachidonic acid by cleaving phospholipids, and a C2 domain responsible for anchoring the pro...
The sphingolipid ceramide‐1‐phosphate (C1P) plays a critical role in the cellular signaling that mediates inflammation, cell proliferation and phagocytosis. C1P has been shown to increase the activity of cytosolic phospholipase A 2 α (cPLA 2 α) as well regulate its translocation to cellular membranes, a process that promotes inflammation through th...
Citations
... Our investigation revealed significant findings for giant unilamellar vesicles (GUVs) incorporating saturated C1P species, notably C1P16, previously documented to induce gel domains 13,30 . The introduction of fluorescently tagged C1P16 has been shown to enhance rigidity and order within the lipid bilayer 31 . Unlike prior observations, autocorrelation curve morphology implies the presence of dual populations, possibly reflecting fluid and gel phases (Fig. S4). ...
... This protein is present on the exosome membrane surface and can combine with S100 (which is known to locate on the cell surface) to form a tetramer. This enhances ceramide-1-phosphate-dependent vascular endothelial cell invasion, which is thought to allow melanoma cells to hijack the exosomal transport of annexins to promote invasion [80][81][82][83][84]. ...
... We did not observe mPFN insertions into the membrane below the hydrophilic heads of POPC. Shallow membrane insertions were also observed in MD simulations of some other C2-domain-containing proteins, such as cytosolic phospholipase A2, PKCa, and synaptotagmin (48,49). PFN maintained an upright orientation during the simulation (120 ns in total) ( Figure 3). ...
... Traditionally, the induction of necrosis by anticancer compounds has been considered as an undesired event in the development of new drugs as it is an uncontrolled way leading to cell death, generally related to extreme conditions that could damage healthy tissues producing important side effects. However, triggering a regulated form of necrosis, i.e. necroptosis, has been described recently as an efficient MoA of some new anticancer drugs [40,41]. This novel paradigm for cytotoxic induction opened the door for alternative ways that could overcome resistance. ...
... With respect to their molecular mechanisms of action, there is a consensus that upon binding Ca 2+ , the C2-domains of syt1 and syt7 partially penetrate membranes that harbor anionic phospholipids 34,35 . This membrane penetration step might serve to destabilize the local phospholipid environment by introducing volume into the bilayer, buckling the membrane, and lowering the energy barrier for fusion 34,[36][37][38][39] . Additionally, membrane penetration could enable syts to regulate SNARE complex assembly 40,41 and stabilize curved intermediate structures 42 . ...
... We have demonstrated the mechanism and importance of the localization of PKC to the cSMAC region of the IS by showing that the V3 (hinge) region between the regulatory and catalytic domains of PKC binds to the cytoplasmic tail of CD28, likely through the kinase Lck, and this association is critical for the downstream functions of PKC in T cells (31). We also demonstrated that, similar to its nearest relative within the PKC family, PKC (35), the N-terminal C2-like domain of PKC is a phosphotyrosine (pTyr)binding domain (36). Nevertheless, the biological relevance of this function of PKC, as well as the identity of the pTyr-containing proteins that associate with the PKC C2 domain in TCR-stimulated T cells, remains to be determined. ...
... Cer can induce cell apoptosis by inhibiting mitochondrial electron transport and triggering the release of cytochrome C. Cytochrome C then activates caspase 3, initiating a cascade of events leading to cell death [114]. Additionally, ceramide kinase can convert Cer to ceramide-1-phosphate (C1P), which may contribute to inflammation by inhibiting tumor necrosis factor-α (TNF-α) signaling [115]. In contrast to the detrimental effects of ceramides, S1P acts as an anti-inflammatory, anti-apoptotic, and pro-proliferative signaling molecule. ...